Serious liver injury from herbal and dietary supplements – including those used by bodybuilders – has risen significantly over the past decade.
According to findings from a review, herbal...
Vedolizumab was not superior to placebo for inducing remission at 6 weeks in patients with Crohn’s disease who failed to respond to anti–tumor necrosis factor therapy, according to findings from the...
A gluten-free diet benefited asymptomatic patients with serologic markers for celiac disease in a prospective randomized study.
The findings support active screening for celiac disease in patients...
Thin actinic keratoses on the face or scalp were 14% more likely to clear completely in patients treated with photodynamic therapy, compared with cryotherapy, in a meta-analysis of four studies...
Coronary artery disease may develop at a younger age in patients with inflammatory bowel disease, even when they have fewer traditional risk factors for heart problems.
A database review of...
Rheumatoid arthritis patients who tested positive for both rheumatoid factor and anticitrullinated protein antibodies showed a greater prevalence and size of bone erosions than did patients who came...
Mutations in the CYP2C genes on chromosome 10 appear to predispose carriers to severe adverse cutaneous reactions to the antiepileptic drug phenytoin, according to a report published Aug. 5 in...
A simulation model that incorporated a one-time universal screening of U.S. adults for hepatitis C virus and made conservative assumptions as to the availability and efficacy of various therapies...
Acetaminophen taken regularly or as required was no better than placebo in improving time to recovery in patients with acute low back pain, Australian research shows.
A randomized,...
The joints of patients with early arthritis that showed subclinical inflammation on MRI had an increased risk of radiographic progression in the first year after disease presentation, particularly...